Buzz
A new FDA regulation has taken effect this week, mandating that mammogram facilities inform patients about their breast density. While 39 states and D.C. previously enforced some form of notification, this rule ensures uniformity across the nation and introduces these alerts to states where they were not previously mandated.
Understanding “Dense” Breast Tissue
Breasts are composed of fat, glandular tissue, and connective tissue. On mammograms, fat shows up as dark regions, while the other tissue types typically appear as white areas.
This is significant because tumors and calcifications also show up as white on mammograms, making it easier to interpret results for individuals with less dense breast tissue. The National Cancer Institute provides visual examples here of the four breast density categories. Breasts classified as “fatty” or with “scattered” dense areas appear darker, while those labeled “heterogeneously dense” or “extremely dense” display more white regions. If you’re informed that you have dense breast tissue, you belong to one of these latter two categories.
Who is likely to have dense breast tissue?
Dense breast tissue is prevalent; the FDA notes that “nearly half” of women over 40 have dense breasts. Factors like using hormone therapy for menopause or having a lower body mass index may increase the likelihood of having dense breasts.
Older individuals and those who have had children are less prone to having dense breasts. However, the tendency to have dense breast tissue is often inherited, as some people naturally have denser tissue than others.
Is having dense breast tissue a concern?
While dense tissue itself isn't harmful, understanding whether you have it is crucial for two main reasons. Firstly, mammograms may miss early cancer signs since distinguishing between normal dense tissue and tumors or calcifications is challenging.
Secondly, individuals with dense breasts appear to have a higher likelihood of developing breast cancer, though the reasons remain unclear. However, having dense breasts does not increase the risk of mortality from breast cancer if diagnosed.
How can I determine if my breast tissue is dense?
Under the new FDA guidelines, your mammogram results will specify which of the four breast tissue categories you fall into. If your tissue is classified as 'mostly fatty' or shows 'scattered fibroglandular densities,' it is deemed non-dense, and the report will state:
Breast tissue varies in density, which can affect cancer detection on mammograms and influence cancer risk. Your results indicate non-dense breast tissue. Discuss breast density, cancer risks, and personal health considerations with your healthcare provider.
If your breast tissue is classified as dense, your report will indicate it is either 'heterogeneously dense, potentially hiding small masses' or 'extremely dense, reducing mammography's effectiveness.' In such cases, the following message will appear:
Breast tissue density varies, impacting both the detectability of cancer on mammograms and the overall risk of developing breast cancer. Your results show dense breast tissue. For some individuals with dense tissue, additional imaging tests alongside mammograms may improve cancer detection. Consult your healthcare provider to discuss breast density, cancer risks, and personalized care options.
What should I do if I’m informed that I have dense breast tissue?
This is where things get complicated. Currently, there isn’t sufficient evidence to determine whether individuals with dense breast tissue should undergo additional or alternative screenings or stick to the standard screening routine without extra tests.
Experts suggest that the decision should be a collaborative one between you and your doctor. The U.S. Preventive Services Task Force has not issued a recommendation, stating that 'existing evidence is inadequate' to evaluate the risks and benefits of additional screenings like breast ultrasound, MRI, or digital breast tomosynthesis for those with dense breasts.
Additional imaging could lead to earlier cancer detection, but it also carries risks, such as unnecessary biopsies or procedures. Insurance coverage for extra imaging, particularly for dense breast tissue, is not always guaranteed.
Your decision to pursue further screenings should factor in your breast cancer risk and personal preferences. While some individuals prefer to take extra precautions, others may prioritize avoiding unneeded interventions. Your doctor can guide you in assessing your risk and weighing the advantages and disadvantages of additional screening.
